Subject: Bush's Medicare Part
Thousands complain about Bush's new prescription
but the White House calls its Part D disaster
Medicare is on President Bush's agenda today as
he heads to upstate New York.
He'll be at a senior center near Rochester. The
visit comes as thousands of Medicare recipients have had
trouble with the administration's new prescription
drug plan. But the White House is calling its Part D disaster
a success, perhaps because it was written to
help big pharmaceutical companies instead of hard-working
people who need prescription drugs to live.
Thousands of people across the country are paying
a price at the pharmacy for this corruption.
They're getting over-charged and facing outrageous
delays, if they're getting their prescriptions at all.
The president's plan is costly, complicated and
Specifically, the president's Part D disaster:
Medicare from negotiating with drug companies to get lower prices for seniors,
coverage to millions of seniors who will still pay monthly premiums this
big insurance companies to take drugs off their coverage list during the
patients are locked in and can't
change their plans.
The Republican prescription drug plan "will cost
New York taxpayers $52.7 billion over the next ten years"
and "deliberately includes waste and inefficiency,"
according to a new report released today by the Campaign
for America's Future. (The report is available
The simplest way to reduce the cost of prescription
drugs would've been to require Medicare to negotiate
lower prices from drug companies like the Veteran's
Adminstration does for veterans and by allowing seniors
to choose their drug plan directly from Medicare,
instead of from a private insurance company.
A separate report released by the Campaign for
America's Future last month shows that specific provisions
of the Medicare prescription drug program inserted
at the request of pharmaceutical and HMO interests will
cost taxpayers and seniors more than $80 billion
a year. The study connects the programís escalating costs
and complexity to the influence exerted by lobbyists
for health insurance, health services and pharmaceutical
companies in drafting the bill. According to
the report, industry campaign contributions totaled $96 million
from 2000 to 2004, and industry profits will
swell by 500 to 600 percent as the new legislation goes into effect.
Campaign for Americaís Future